Načítá se...
Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis
BACKGROUND: Metformin use has been associated with a reduced risk of developing cancer and an improvement in overall cancer survival rates in meta-analyses, but, to date, evidence to support the use of metformin as an adjuvant therapy in individual cancer types has not been presented. PATIENTS AND M...
Uloženo v:
| Vydáno v: | Ann Oncol |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5178140/ https://ncbi.nlm.nih.gov/pubmed/27681864 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdw410 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|